A detailed history of Cwc Advisors, Llc. transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Cwc Advisors, Llc. holds 16,150 shares of TGTX stock, worth $393,414. This represents 0.37% of its overall portfolio holdings.

Number of Shares
16,150
Holding current value
$393,414
% of portfolio
0.37%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

BUY
$17.21 - $25.28 $277,941 - $408,272
16,150 New
16,150 $378 Million

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $3.54B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Cwc Advisors, Llc. Portfolio

Follow Cwc Advisors, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwc Advisors, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Cwc Advisors, Llc. with notifications on news.